Workflow
中国化学(601117):2025年半年报点评:盈利能力继续改善,海外收入占比提升至30%

Investment Rating - The report maintains a "Buy" rating for the company [5][11] Core Views - The company's revenue for H1 2025 was 90.72 billion, a slight decrease of 0.35% year-on-year, while the net profit attributable to shareholders increased by 9.26% to 3.10 billion [1][5] - The proportion of overseas revenue has significantly increased to 30%, with a year-on-year growth of 29% in overseas income [1][3] - The company has signed new contracts worth 224.85 billion from January to July 2025, representing a year-on-year increase of 4.38%, with the chemical engineering segment contributing 176.59 billion, up 9.80% [3] Summary by Sections Financial Performance - In H1 2025, the company's gross margin increased by 0.19 percentage points to 9.58%, with specific improvements in the chemical engineering and infrastructure segments [2] - The net profit margin rose by 0.30 percentage points to 3.74%, despite a significant increase in operating cash outflow, which reached -10.03 billion, a year-on-year increase of 119.47% [2] Revenue Breakdown - Revenue from chemical engineering, infrastructure, environmental governance, and new materials for H1 2025 was 74.81 billion, 9.11 billion, 0.51 billion, and 4.83 billion respectively, with varying year-on-year changes [1] - Domestic revenue decreased by 8.93% to 63.47 billion, while overseas revenue increased by 28.75% to 26.60 billion [1] Future Projections - The company expects net profits for 2025, 2026, and 2027 to be 6.31 billion, 6.85 billion, and 7.41 billion respectively, with corresponding EPS of 1.03, 1.12, and 1.21 [3][4]